Flavonoid-induced ability of minimally modified low-density lipoproteins to support lymphocyte proliferation

被引:20
作者
Carrero, P
Ortega, H
Martínez-Botas, J
Gómez-Coronado, D
Lasunción, MA
机构
[1] Hosp Ramon y Cajal, Serv Bioquim Invest, Madrid 28034, Spain
[2] Univ Alcala de Henares, Madrid, Spain
关键词
minimally modified LDL; lipoperoxidation; cell proliferation; flavonoids; wine; lymphocyte;
D O I
10.1016/S0006-2952(97)00635-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Low-density lipoprotein (LDL) peroxidation appears to be involved in atherogenesis. We studied the ability of minimally modified LDL (MM-LDL) to be used by proliferating lymphocytes and the effects of antioxidant flavonoids on this lipoprotein. MM-LDL were obtained by storing LDL at 4 degrees for 1 month, which resulted in a decrease in lipophilic antioxidants and an increased susceptibility to oxidation when incubated with cells. MM-LDL were not cytotoxic; however, in cells treated with lovastatin that require cholesterol for cell growth, they were much less efficient than fresh LDL in sustaining proliferation as determined by [H-3]thymidine incorporation into DNA. Pure quercetin and grape-derived beverages restored proliferation in the presence of MM-LDL and prevented the apoptosis otherwise induced by lovastatin. These effects of flavonoids correlated with their activity in inhibiting LDL peroxidation. The results demonstrate that potent antioxidants, such as flavonoids, protect MM-LDL from lipoperoxidation and preserve their ability to efficiently deliver cholesterol to cells. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1125 / 1129
页数:5
相关论文
共 22 条
[1]  
AVILA MA, 1994, CANCER RES, V54, P2424
[2]   VITAMIN-E CONTENT AND LOW-DENSITY-LIPOPROTEIN OXIDIZABILITY INDUCED BY FREE-RADICALS [J].
BABIY, AV ;
GEBICKI, JM ;
SULLIVAN, DR .
ATHEROSCLEROSIS, 1990, 81 (03) :175-182
[3]   MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[4]  
CAMEJO G, 1991, J LIPID RES, V32, P1983
[5]  
CHISOLM GM, 1991, CURR OPIN LIPIDOL, V2, P311
[6]  
CHUNG BH, 1986, METHOD ENZYMOL, V128, P181
[7]  
CUTHBERT JA, 1990, J BIOL CHEM, V265, P18568
[8]   FLAVONOIDS INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY MACROPHAGES [J].
DEWHALLEY, CV ;
RANKIN, SM ;
HOULT, JRS ;
JESSUP, W ;
LEAKE, DS .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (11) :1743-1750
[9]   ABSORPTION OF DIETARY QUERCETIN GLYCOSIDES AND QUERCETIN IN HEALTHY ILEOSTOMY VOLUNTEERS [J].
HOLLMAN, PCH ;
DEVRIES, JHM ;
VANLEEUWEN, SD ;
MENGELERS, MJB ;
KATAN, MB .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 62 (06) :1276-1282
[10]   CHANGES IN LIPOPROTEIN(A), LDL-CHOLESTEROL AND APOLIPOPROTEIN-B IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH DEXTRAN SULFATE LDL-APHERESIS [J].
LASUNCION, MA ;
TERUEL, JL ;
ALVAREZ, JJ ;
CARRERO, P ;
ORTUNO, J ;
GOMEZCORONADO, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (12) :819-826